Search Results - "ASHCRAFT, Deborah"
-
1
Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii
Published in International journal of antimicrobial agents (01-05-2019)“…•New antimicrobials are needed for carbapenem-resistant Acinetobacter baumannii.•Nisin is an FDA-approved antibacterial peptide currently used as a food…”
Get full text
Journal Article -
2
Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program
Published in Antimicrobial agents and chemotherapy (01-10-2015)“…Two linezolid-resistant Enterococcus faecium isolates (MICs, 8 μg/ml) from unique patients of a medical center in New Orleans were included in this study…”
Get full text
Journal Article -
3
Fracture Resistance of Titanium‐Based Lithium Disilicate and Zirconia Implant Restorations
Published in Journal of prosthodontics (01-08-2018)“…Purpose To evaluate the fracture resistance of a newer lithium disilicate abutment material. Materials and Methods A premolar‐shaped implant crown was designed…”
Get full text
Journal Article -
4
Evaluation of the in vitro interaction of fosfomycin and meropenem against metallo-β-lactamase–producing Pseudomonas aeruginosa using Etest and time-kill assay
Published in Journal of investigative medicine (01-02-2021)“…Pseudomonas aeruginosa is a nosocomial pathogen containing various resistance mechanisms. Among them, metallo-β-lactamase (MBL)–producing Pseudomonas are…”
Get full text
Journal Article -
5
In vitro interaction of fluconazole and trimethoprim–sulfamethoxazole against Candida auris using ETEST and checkerboard methods
Published in Journal of investigative medicine (01-01-2021)“…Candida auris was discovered in 2009 and has rapidly emerged as a serious public health threat with cases reported in over 20 countries worldwide. As of May 8,…”
Get full text
Journal Article -
6
In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enterococcus faecium
Published in Journal of global antimicrobial resistance. (01-09-2020)“…•Enterococcus is the second leading cause of health care–associated infections.•Linezolid resistance in vancomycin-resistant enterococci (VRE) is…”
Get full text
Journal Article -
7
Comparison of 3 Etest® methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species
Published in Diagnostic microbiology and infectious disease (01-11-2013)“…Abstract Increasing global antibiotic resistance has resulted in more use of antibiotic combinations. There is a lack of a gold standard for in vitro testing…”
Get full text
Journal Article -
8
Comparing antimicrobial resistant genes and phenotypes across multiple sequencing platforms and assays for Enterobacterales clinical isolates
Published in BMC microbiology (18-08-2023)“…Whole genome sequencing (WGS) of bacterial isolates can be used to identify antimicrobial resistance (AMR) genes. Previous studies have shown that…”
Get full text
Journal Article -
9
In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates
Published in Medical mycology (Oxford) (01-01-2019)“…Abstract Candida species, traditionally viewed as opportunistic agents, are increasingly seen as a cause of infection in hospitalized patients. Treatment…”
Get full text
Journal Article -
10
Genetic Divergence of Vibrio vulnificus Clinical Isolates with Mild to Severe Outcomes
Published in mBio (26-10-2022)“…The marine bacterium Vibrio vulnificus infects humans via food or water contamination, leading to serious manifestations, including gastroenteritis, wound…”
Get full text
Journal Article -
11
In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata
Published in The American journal of the medical sciences (01-03-2016)“…Abstract Background Candida species account for most invasive fungal infections, and the emergence of fluconazole and caspofungin resistance is problematic…”
Get full text
Journal Article -
12
Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae
Published in Diagnostic microbiology and infectious disease (01-08-2011)“…Abstract Polymyxin B (PB) plus meropenem (MER) or rifampin (RIF) was tested by Etest® method and time-kill assay (TKA) against 14 genetically unique clinical…”
Get full text
Journal Article -
13
Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates in southeast Louisiana reveals persistent genetic clusters spanning multiple locations
Published in Journal of infection and public health (01-12-2023)“…We investigated 51 g-negative carbapenem-resistant Enterobacterales (CRE) isolates collected from 22 patients over a five-year period from six health care…”
Get full text
Journal Article -
14
In Vitro Synergy of Ciprofloxacin and Gatifloxacin against Ciprofloxacin-Resistant Pseudomonas aeruginosa
Published in Antimicrobial Agents and Chemotherapy (01-07-2005)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
15
In Vitro Synergy of Daptomycin plus Rifampin against Enterococcus faecium Resistant to both Linezolid and Vancomycin
Published in Antimicrobial Agents and Chemotherapy (01-12-2005)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
16
The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay
Published in Diagnostic microbiology and infectious disease (01-02-2009)“…Abstract Time-kill assay and Etest testing for synergy of meropenem (MER) (1× MIC) plus polymyxin B (1/4, 1/2, and 1× MIC) were performed against 8 genetically…”
Get full text
Journal Article -
17
In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time–kill assay
Published in Diagnostic microbiology and infectious disease (01-07-2009)“…Abstract This time–kill study was performed with 65 genetically unique clinical isolates of Gram-negative bacilli and enterococci to further define the…”
Get full text
Journal Article -
18
In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia
Published in Diagnostic microbiology and infectious disease (01-07-2010)“…Abstract Synergy testing of levofloxacin and meropenem by Etest and time–kill assay (TKA) was performed against 30 genetically unique clinical Stenotrophomonas…”
Get full text
Journal Article -
19
In Vitro Synergy of Telavancin and Rifampin Against Enterococcus faecium Resistant to Both Linezolid and Vancomycin
Published in The Ochsner journal (2013)“…An emerging pathogen is Enterococcus faecium resistant to both linezolid and vancomycin (LRVRE). Antimicrobial combinations may be required for therapy and…”
Get full text
Journal Article -
20
Bacteremia Due to Bacteroides fragilis Group: Distribution of Species, β-Lactamase Production, and Antimicrobial Susceptibility Patterns
Published in Antimicrobial Agents and Chemotherapy (01-01-2003)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article